BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33223074)

  • 1. Clinical staging accuracy and the use of neoadjuvant chemoradiotherapy for cT3N0 rectal cancer: Propensity score matched National Cancer Database analysis.
    Burneikis D; Lavryk O; Gorgun E; Liska D; Valente M; Sklow B; Kalady M; Steele SR
    Am J Surg; 2021 Mar; 221(3):561-565. PubMed ID: 33223074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinically-staged T3N0 rectal cancer: is preoperative chemoradiotherapy the optimal treatment?
    Lombardi R; Cuicchi D; Pinto C; Di Fabio F; Iacopino B; Neri S; Tardio ML; Ceccarelli C; Lecce F; Ugolini G; Pini S; Di Tullio P; Taffurelli M; Minni F; Martoni A; Cola B
    Ann Surg Oncol; 2010 Mar; 17(3):838-45. PubMed ID: 20012700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can we eliminate neoadjuvant chemoradiotherapy in favor of neoadjuvant multiagent chemotherapy for select stage II/III rectal adenocarcinomas: Analysis of the National Cancer Data base.
    Cassidy RJ; Liu Y; Patel K; Zhong J; Steuer CE; Kooby DA; Russell MC; Gillespie TW; Landry JC
    Cancer; 2017 Mar; 123(5):783-793. PubMed ID: 27780316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant chemoradiation improves oncologic outcomes in low and mid clinical T3N0 rectal cancers.
    Lavryk OA; Manilich E; Valente MA; Miriam A; Gorgun E; Kalady MF; Shawki S; Delaney CP; Steele SR
    Int J Colorectal Dis; 2020 Jan; 35(1):77-84. PubMed ID: 31776698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy analysis of neoadjuvant chemoradiotherapy combined with total pelvic exenteration in the treatment of primary T4b rectal cancer].
    Wu T; Wen L; Zhang J; Wu Y; Jiang Y; Chen G; Wang X; Huang S; Wan Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):59-65. PubMed ID: 30703795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does one size fit all? Risks and benefits of neoadjuvant chemoradiation in patients with clinical stage IIA rectal cancer requiring abdominoperineal resection.
    de Camargo MGM; Xhaja X; Aiello A; Liska D; Gorgun E; Dietz DW; Kalady MF; Delaney CP; Steele SR; Valente MA
    Am J Surg; 2020 Mar; 219(3):406-410. PubMed ID: 31672306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant chemo-radiotherapy for cT3N0 rectal cancer: any benefit over upfront surgery? A propensity score-matched study.
    Sorrentino L; Guaglio M; Battaglia L; Bonfanti G; Vitellaro M; Bianchi AC; Milione M; Belli F
    Int J Colorectal Dis; 2019 Dec; 34(12):2161-2169. PubMed ID: 31741026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant chemoradiation followed by transanal local excision for T2 rectal cancer confers equivalent survival benefit as traditional transabdominal resection.
    Jawitz OK; Adam MA; Turner MC; Gilmore BF; Migaly J
    Surgery; 2019 Jun; 165(6):1193-1198. PubMed ID: 30904173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does Delaying Surgical Resection After Neoadjuvant Chemoradiation Impact Clinical Outcomes in Locally Advanced Rectal Adenocarcinoma?: A Single-Institution Experience.
    Nguyen P; Wuthrick E; Chablani P; Robinson A; Simmons L; Wu C; Arnold M; Harzman AE; Husain S; Schmidt C; Abdel-Misih S; Bekaii-Saab T; Chakravarti A; Williams TM
    Am J Clin Oncol; 2018 Feb; 41(2):140-146. PubMed ID: 26535992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerability, Safety, and Outcomes of Neoadjuvant Chemoradiotherapy With Capecitabine for Patients Aged ≥ 70 Years With Locally Advanced Rectal Cancer.
    Jacobs L; van der Vlies E; Ten Bokkel Huinink D; Bloemendal H; Intven M; Smits AB; Weusten BLAM; Siersema PD; van Lelyveld N; Los M
    Clin Colorectal Cancer; 2018 Sep; 17(3):179-186. PubMed ID: 29661620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endorectal ultrasound does not reliably identify patients with uT3 rectal cancer who can avoid neoadjuvant chemoradiotherapy.
    Shapiro R; Ahmed Ali U; Lavery IC; Kiran RP
    Int J Colorectal Dis; 2013 Jul; 28(7):993-1000. PubMed ID: 23377857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved Metastasis- and Disease-Free Survival With Preoperative Sequential Short-Course Radiation Therapy and FOLFOX Chemotherapy for Rectal Cancer Compared With Neoadjuvant Long-Course Chemoradiotherapy: Results of a Matched Pair Analysis.
    Markovina S; Youssef F; Roy A; Aggarwal S; Khwaja S; DeWees T; Tan B; Hunt S; Myerson RJ; Chang DT; Parikh PJ; Olsen JR
    Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):417-426. PubMed ID: 28871992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Outcomes of Preoperative Chemoradiotherapy and Selective Postoperative Chemoradiotherapy in Clinical Stage T3N0 Low and Mid Rectal Cancer.
    Lin Y; Lin H; Xu Z; Zhou S; Chi P
    J Invest Surg; 2019 Nov; 32(7):679-687. PubMed ID: 30215538
    [No Abstract]   [Full Text] [Related]  

  • 14. No benefit after neoadjuvant chemoradiation in stage IV rectal cancer: A propensity score-matched analysis on a real-world population.
    Milito P; Sorrentino L; Pietrantonio F; Di Russo A; Citterio D; Mazzaferro V; Cosimelli M
    Dig Liver Dis; 2021 Aug; 53(8):1041-1047. PubMed ID: 33487580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Implications of Pathological Response to Neoadjuvant Chemoradiation in Pathologic Stage III Rectal Cancer.
    Karagkounis G; Thai L; Mace AG; Wiland H; Pai RK; Steele SR; Church JM; Kalady MF
    Ann Surg; 2019 Jun; 269(6):1117-1123. PubMed ID: 31082910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer].
    Zhai ZW; Zhang KN; Wang C; Han JG; Ma HC; Wei GH; Yang Y; Wang ZJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):274-280. PubMed ID: 32192307
    [No Abstract]   [Full Text] [Related]  

  • 17. Adjuvant Chemotherapy Is Associated With Improved Overall Survival in Locally Advanced Rectal Cancer After Achievement of a Pathologic Complete Response to Chemoradiation.
    Shahab D; Gabriel E; Attwood K; Ma WW; Francescutti V; Nurkin S; Boland PM
    Clin Colorectal Cancer; 2017 Dec; 16(4):300-307. PubMed ID: 28420585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of neoadjuvant chemotherapy with or without intensity-modulated radiotherapy for patients with rectal cancer.
    He F; Yu L; Ding Y; Li ZH; Wang J; Zheng J; Chen HY; Liu S; Pang XL; Ajani JA; Wan XB
    Cancer Sci; 2020 Nov; 111(11):4205-4217. PubMed ID: 32860448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Different Nodal Staging in Patients With Locally Advanced Mid-low Rectal Cancer After Long-term Neoadjuvant Chemoradiation Therapy.
    Petrucciani N; Carra MC; Martínez-Pérez A; Vitali GC; Landi F; Genova P; Memeo R; Brunetti F; Espin E; Ris F; De'angelis N;
    Anticancer Res; 2019 Apr; 39(4):2113-2120. PubMed ID: 30952757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended Intervals after Neoadjuvant Therapy in Locally Advanced Rectal Cancer: The Key to Improved Tumor Response and Potential Organ Preservation.
    Probst CP; Becerra AZ; Aquina CT; Tejani MA; Wexner SD; Garcia-Aguilar J; Remzi FH; Dietz DW; Monson JR; Fleming FJ;
    J Am Coll Surg; 2015 Aug; 221(2):430-40. PubMed ID: 26206642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.